当前位置: 首页 > 期刊 > 《中国医药科学》 > 2022年第10期
编号:113357
类风湿关节炎患者地塞米松戒断综合征2例并文献复习
http://www.100md.com 2022年7月11日 中国医药科学 2022年第10期
国药准字,氢化,泼尼松
     张丽琼 田源

    [摘要]地塞米松戒断综合征是指使用地塞米松数月或更长时间停药后所产生的全身多系统的临床表现。目前国内对该病的报道较少。医务工作者经常忽视糖皮质激素戒断综合征(GCWS),尤其对于选择糖皮质激素维持治疗的类风湿关节炎(RA)患者,突发疾病住院中断激素治疗,临床表现复杂,诊断难度大,患者住院时间延长。通过报道2例长期服用小剂量地塞米松的 RA 患者并发髋臼骨折和空腔脏器穿孔的诊治经过,结合文献对 GCWS 的临床表现发生机制、诊断、治疗用药品种选择和围手术期 GCWS 品种选择进行探讨,以提高医务工作者对 GCWS 的认识。

    [关键词]糖皮质激素;戒断综合征;停药反应;类风湿关节炎;地塞米松

    [中图分类号] R453[文献标识码] A [文章编号]2095-0616(2022)10-0193-04

    Dexamethasonewithdrawalsyndromein 2 patientswith rheumatoid arthritis and literature review

    ZHANGLiqiongTIANYuan

    Department of Pharmacy, the Second People's Hospital of Qujing City, Yunnan, Qujing 655000, China

    [Abstract] Dexamethasone withdrawal syndrome refers to the clinical manifestations of multiple systems throughout the body that occur after several months or longer of dexamethasone withdrawal. At present, there are few reports on this disease in China. Glucocorticoid withdrawal syndrome (GCWS) is often overlooked by medical workers, especially in patients with rheumatoid arthritis (RA) who choose glucocorticoid maintenance therapy. If hormone therapy is interrupted during hospitalization due to sudden illness ......

您现在查看是摘要页,全文长 13817 字符